Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification - Pérez de Ciriza, C; Moreno, M; Restituto, P; Bastarrika, G; Simón, I; Colina, I; Varo, N (Clin Biochem, 2014)